IGFBP5
IGFBP5，全稱為胰島素樣生長因子結(jié)合蛋白5，是一種重要的蛋白質(zhì)，在人體內(nèi)發(fā)揮著多種生理功能。它也被稱為IGFBP-5或IBP5，屬于IGFBP家族的一員。IGFBP5的主要作用是結(jié)合胰島素樣生長因子（IGF），調(diào)節(jié)IGF的生物利用度和功能。它能夠延長IGF的半衰期，并通過改變與IGF受體相互作用的動力學來抑制或刺激細胞對IGF的反應。IGFBP5還參與多種細胞過程，包括細胞生長、遷移、增殖和凋亡。研究表明，IGFBP5在多種疾病的發(fā)生發(fā)展中起著重要作用，如糖尿病腎臟病、急性腎損傷和腫瘤等。在藥物研發(fā)方面，IGFBP5已成為一個重要的靶點。目前，已有多種針對IGFBP5的藥物正在進行臨床研究，以期用于治療糖尿病、癌癥等疾病。
熱銷產(chǎn)品
Recombinant Human Insulin-like growth factor-binding protein 5 (IGFBP5) (CSB-EP011099HU)
驗證數(shù)據(jù)
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
IGFBP5 Antibody (CSB-PA011099KA01HU)
驗證數(shù)據(jù)
Western blot analysis of extracts of HEK-293T cell lines, using IGFBP5 antibody.
Human insulin-like growth factor binding protein 5,IGFBP-5 ELISA Kit (CSB-E13263h)
驗證數(shù)據(jù)
貨號：CSB-E13263h
規(guī)格：96T/48T
靈敏度：0.039 ng/mL
檢測范圍：0.156 ng/mL-10 ng/mL
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
IGFBP5 Antibodies
IGFBP5 for Homo sapiens (Human)
| 產(chǎn)品貨號 | 產(chǎn)品名稱 | 種屬反應性 | 應用類型 |
|---|---|---|---|
| CSB-PA011099KA01HU | IGFBP5 Antibody | Human,Mouse,Rat | ELISA,WB,IHC |
| CSB-PA372865 | IGFBP5 Antibody | Human,Mouse,Rat | ELISA,IHC |
IGFBP5 Proteins
IGFBP5 Proteins for Homo sapiens (Human)
| 產(chǎn)品貨號 | 產(chǎn)品名稱 | 來源 |
|---|---|---|
| CSB-YP011099HU CSB-BP011099HU CSB-MP011099HU CSB-EP011099HU-B |
Recombinant Human Insulin-like growth factor-binding protein 5 (IGFBP5) | Yeast Baculovirus Mammalian cell In Vivo Biotinylation in E.coli |
| CSB-AP002501HU | Recombinant Human Insulin-like growth factor-binding protein 5 protein (IGFBP5) | E.Coli |
| CSB-EP011099HU | Recombinant Human Insulin-like growth factor-binding protein 5 (IGFBP5) | E.coli |
IGFBP5 ELISA Kit
IGFBP5 ELISA Kit for Homo sapiens (Human)
| 產(chǎn)品貨號 | 產(chǎn)品名稱 | 樣本類型 | 靈敏度 |
|---|---|---|---|
| CSB-E13263h | Human insulin-like growth factor binding protein 5,IGFBP-5 ELISA Kit | serum, plasma, cell culture supernates | 0.039 ng/mL |
